BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Danguilan RA, Lamban A, Pamugas GEP. Pilot Study Comparing the Efficacy, Safety, Convertibility, and Tacrolimus Trough Levels of Twice-Daily Tacrolimus (Prograf) to Once-Daily Tacrolimus (Advagraf) Among Standard-Risk Kidney Transplant Patients at the National Kidney and Transplant Institute. Transplant Proc 2019;51:2615-9. [PMID: 31563241 DOI: 10.1016/j.transproceed.2019.05.019] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Ferhatoglu MF, Kartal A, Kivilcim T, Filiz AI, Yildiz G, Gurkan A. A Comparative Analysis of Once-daily and Twice-daily Formulation of Tacrolimus in De Novo Kidney Transplant Recipients. Sisli Etfal Hastan Tip Bul 2021;55:62-7. [PMID: 33935537 DOI: 10.14744/SEMB.2020.71235] [Reference Citation Analysis]